Malaria burden was measured by the prevalence and density of infection, the prevalence of clinical malaria and the prevalence of anti-CSP antibodies which can be used as a sero-epidemiological marker of the exposure to malaria transmission [4,37,39,40]. Here, DNAJC5 is linked to infection.